Cannabics Pharmaceuticals, Inc.(Other OTC/NBB : CNBX)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | -1.08% | 278.82 | 1.4% | $741.23m | |
| AMGN | Amgen, Inc. | -0.74% | 203.32 | 1.3% | $386.61m | |
| CELG | Celgene Corp. | 0.28% | 104.99 | 1.3% | $376.93m | |
| GILD | Gilead Sciences, Inc. | 1.09% | 66.58 | 1.0% | $375.52m | |
| ILMN | Illumina, Inc. | 1.15% | 312.59 | 3.5% | $232.71m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.29% | 190.51 | 1.9% | $216.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.23% | 305.02 | 2.6% | $210.35m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 7.40% | 106.63 | 1.9% | $181.77m | |
| EXAS | EXACT Sciences Corp. | -1.52% | 87.50 | 24.0% | $173.24m | |
| A | Agilent Technologies, Inc. | 0.38% | 74.97 | 1.6% | $132.59m | |
| SGEN | Seattle Genetics, Inc. | 1.34% | 99.96 | 6.2% | $132.30m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.67% | 84.12 | 14.6% | $125.03m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.89% | 69.01 | 4.3% | $96.83m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.21% | 18.88 | 10.2% | $94.86m | |
| NKTR | Nektar Therapeutics | -2.50% | 16.77 | 5.5% | $80.05m |
Company Profile
Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.